Press Release

Global Synthetic Hormones Market to grow with a CAGR of 12.20%.

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Synthetic Hormones Market.

 

According to TechSci Research report, “Global Synthetic Hormones Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Synthetic Hormones Market has valued at USD 470.20 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 12.20% through 2028.  This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market. Advancements in drug delivery technology serve as a driver for the global synthetic hormones market. Drug delivery innovations have the potential to enhance the effectiveness, safety, and patient experience of synthetic hormone therapies. Innovative drug delivery methods can make it easier for patients to adhere to their treatment regimens. For example, long-acting or extended-release formulations allow for less frequent dosing, reducing the burden of daily medication and improving patient compliance. Drug delivery systems can improve the bioavailability of synthetic hormones, ensuring that a larger proportion of the administered dose reaches its target site. This can lead to more effective treatment outcomes with lower doses and reduced side effects. Advanced drug delivery technologies enable precise control over dosages, allowing healthcare providers to tailor treatment regimens to individual patient needs. This personalization can optimize therapeutic outcomes. Targeted drug delivery systems can deliver synthetic hormones directly to specific tissues or organs, minimizing systemic exposure and reducing side effects. For example, hormone-releasing intrauterine devices (IUDs) provide localized delivery for contraception or hormone therapy. Transdermal patches and topical creams or gels offer convenient and non-invasive methods for hormone replacement therapy (HRT). They can provide steady, controlled hormone release through the skin, avoiding the need for oral administration.

 

Browse over XX market data Figures and spread through 110 Pages and an in-depth TOC on " Global Synthetic Hormones Market

 

In the therapy of hormonal imbalance in the human body, synthetic hormones, which are foreign chemicals created in a lab, are employed. Progesterone, oestrogen, thyroid hormone, testosterone, and insulin are just a few of the synthetic hormones that are often utilized for various medical ailments. The Ferring B.V. product Zomacton injectable (Somatropin), which is used to treat growth hormone insufficiency in children, is one example of the synthetic hormones that are sold on the market. Additionally, Tirosint from IBSA Institute Biochimique SA is offered as a liquid levothyroxine formulation for the treatment of hypothyroidism in people with thyroid hormone insufficiency.

In February 2022, The European Commission has approved the once-weekly injection of NGENLA (somatrogon), a next-generation long-acting recombinant human growth hormone, to treat children and adolescents from the age of three who have growth disturbances caused by insufficient growth hormone secretion. NGENLA offers paediatric kids with growth hormone deficiency (GHD), their careers, and healthcare professionals a novel therapy option that lowers the frequency of necessary injections from once daily to once weekly. NGENLA (somatrogon) is a synthetic growth hormone that works by replacing the lack of growth hormone in the body. NGENLA is taken by injection just below the skin. Compared to the growth hormone GENOTROPIN (somatropin), its action in the body lasts longer, enabling weekly injections instead of daily. GHD is a rare disease characterized by the inadequate secretion of the growth hormone, somatropin, from the pituitary gland and affects one in approximately 4,000 to 10,000 children worldwide. The disease can be caused by genetic mutations or acquired after birth. Without treatment, affected children will have persistent growth attenuation and a very short height in adulthood, and puberty may be delayed. Children may also experience other problems with physical health and mental well-being.

Regulatory scrutiny is a significant challenge in the global synthetic hormones market, as it is in the broader pharmaceutical industry. Regulatory bodies play a crucial role in ensuring the safety, efficacy, and quality of synthetic hormone medications. Pharmaceutical companies must adhere to strict regulatory guidelines throughout the drug development process, including manufacturing practices, quality control, and labeling requirements. Non-compliance can result in delays, fines, or the withdrawal of a drug from the market. The labeling and packaging of synthetic hormone medications must provide clear and accurate information to healthcare providers and patients. Any changes to labeling require regulatory approval. Ensuring the consistent quality and potency of synthetic hormone products is essential. Manufacturing facilities and processes are subject to regular inspections and quality checks by regulatory authorities to maintain product safety and efficacy.

Global Synthetic Hormones Market segmentation is based on Product, Route of Administration, Application, End User, and Region


Based on Application, Global Synthetic Hormones Market is segmented into Growth Hormone Deficiency, Male Hypogonadism, Menopause, Thyroid Hormone Deficiency. Thyroid hormone deficiency, also known as hypothyroidism, is a medical condition characterized by an insufficient production or inadequate functioning of thyroid hormones by the thyroid gland. The thyroid gland, located in the front of the neck, plays a crucial role in regulating various metabolic processes in the body. When it fails to produce enough thyroid hormones, it can lead to a range of physical and metabolic problems. The thyroid gland produces two primary hormones, thyroxine (T4) and triiodothyronine (T3). These hormones are responsible for regulating the body's metabolism, which includes processes like energy production, temperature regulation, and the functioning of various organs and tissues. Hypothyroidism is typically diagnosed through blood tests that measure levels of thyroid-stimulating hormones (TSH) and thyroid hormones (T4 and T3). Elevated TSH levels with low T4 and T3 levels are indicative of hypothyroidism. The most common treatment for thyroid hormone deficiency is hormone replacement therapy. Patients are prescribed synthetic thyroid hormones, typically levothyroxine (T4), which they take as a daily oral medication. The goal of treatment is to restore normal thyroid hormone levels and alleviate symptoms.

Based on Region, North America dominated the Global Synthetic Hormones Market. North America has robust regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, which ensure the safety and efficacy of pharmaceutical products, including synthetic hormones. A clear and well-established regulatory framework supports the market's growth and stability. Many residents in North America have access to health insurance, which can cover the cost of hormone replacement therapies and treatments. This makes synthetic hormones more accessible and affordable to a larger portion of the population. North America conducts a significant portion of clinical trials for new hormone therapies. This not only contributes to scientific advancements but also establishes the region as a hub for hormone-related research and development. The overall economic prosperity of North America means that consumers have the financial capacity to afford synthetic hormone treatments.

Asia-pacific region to fastest growth in the Global Synthetic Hormones Market. The Asia-Pacific region is home to a significant portion of the world's population, including countries like China and India, which have populations exceeding one billion each. A large and growing population creates a substantial patient base for healthcare services and pharmaceutical products, including synthetic hormones. Like many other parts of the world, the Asia-Pacific region is experiencing demographic shifts, with a rapidly aging population. As people age, they are more likely to develop hormone-related disorders and require hormone replacement therapies, driving demand for synthetic hormones. Many countries in the Asia-Pacific region are investing in improving their healthcare infrastructure, expanding access to healthcare services, and enhancing the availability of pharmaceutical products. This increased access to healthcare contributes to greater diagnosis and treatment of hormone-related conditions. Urbanization, changing dietary habits, and sedentary lifestyles have contributed to an increase in lifestyle-related hormone disorders, such as diabetes and obesity. These factors drive the need for hormone management and treatment with synthetic hormones.

 

Some of the major companies operating in the Global Synthetic Hormones Market include:

  • Acerus Pharmaceuticals Corp.
  • American Regent, Inc.
  • Anhui Anke Biotechnology (Group) Co. Ltd.
  • BioPartners, Inc
  • Eli Lilly and Company
  • Endo Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd.
  • IBSA Institut Biochimique SA
  • Lupin Pharmaceuticals, Inc.
  • Pfizer, Inc

 

Download Free Sample Report

Customers can also request 10% free customization on this report.


“Certain areas, particularly in North America, are projected to exert significant demand for thyroid treatment. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Synthetic Hormones Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

Synthetic Hormones Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028  Segmented by Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), by Route of Administration (Intravenous, Nasal, Oral, Suppository, Topical), by Application (Growth Hormone Deficiency, Male Hypogonadism, Menopause, Thyroid Hormone Deficiency), by End User (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by region, and Competition evaluated the future growth potential of Global Synthetic Hormones Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Synthetic Hormones Market.


Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: www.techsciresearch.com               

Relevant News